These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8976364)
1. Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features. Pejovic T; Iosif CS; Mitelman F; Heim S Cancer Genet Cytogenet; 1996 Dec; 92(2):95-8. PubMed ID: 8976364 [TBL] [Abstract][Full Text] [Related]
2. Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F Genes Chromosomes Cancer; 1990 May; 2(1):48-52. PubMed ID: 2177641 [TBL] [Abstract][Full Text] [Related]
3. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms. Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855 [TBL] [Abstract][Full Text] [Related]
4. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232 [TBL] [Abstract][Full Text] [Related]
5. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours. Evans MF; McDicken IW; Herrington CS J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488 [TBL] [Abstract][Full Text] [Related]
6. Trisomy 12 and K-ras-2 amplification in human ovarian tumors. Yang-Feng TL; Li SB; Leung WY; Carcangiu ML; Schwartz PE Int J Cancer; 1991 Jul; 48(5):678-81. PubMed ID: 2071229 [TBL] [Abstract][Full Text] [Related]
7. Trisomy of chromosome 10 in two cases of ovarian carcinoma. Wang J; Mes-Masson AM; Tonin PN; Provencher D; Eydoux P Cancer Genet Cytogenet; 2000 Apr; 118(1):65-8. PubMed ID: 10731594 [TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Persons DL; Hartmann LC; Herath JF; Keeney GL; Jenkins RB Am J Clin Pathol; 1994 Dec; 102(6):775-9. PubMed ID: 7801890 [TBL] [Abstract][Full Text] [Related]
9. Genomic imbalances in ovarian borderline serous and mucinous tumors. Hu J; Khanna V; Jones MM; Surti U Cancer Genet Cytogenet; 2002 Nov; 139(1):18-23. PubMed ID: 12547152 [TBL] [Abstract][Full Text] [Related]
10. Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Caduff RF; Svoboda-Newman SM; Ferguson AW; Johnston CM; Frank TS Am J Surg Pathol; 1999 Mar; 23(3):323-8. PubMed ID: 10078924 [TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163 [TBL] [Abstract][Full Text] [Related]
12. Borderline malignant serous tumors of the ovary maintained on extracellular matrix: evidence for clonal evolution and invasive potential. Crickard K; Marinello MJ; Crickard U; Satchidanand SK; Yoonessi M; Caglar H Cancer Genet Cytogenet; 1986 Oct; 23(2):135-43. PubMed ID: 3756833 [TBL] [Abstract][Full Text] [Related]
13. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Staebler A; Heselmeyer-Haddad K; Bell K; Riopel M; Perlman E; Ried T; Kurman RJ Hum Pathol; 2002 Jan; 33(1):47-59. PubMed ID: 11823973 [TBL] [Abstract][Full Text] [Related]
15. Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors. Bello MJ; Rey JA Int J Cancer; 1990 Jan; 45(1):50-4. PubMed ID: 2298505 [TBL] [Abstract][Full Text] [Related]
16. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization. Mark HF; Afify AM; Werness BA; Das S; Mark S; Samy M Exp Mol Pathol; 1999 Apr; 66(1):76-81. PubMed ID: 10331967 [TBL] [Abstract][Full Text] [Related]
17. p53 expression in ovarian borderline tumors and stage I carcinomas. Kupryjańczyk J; Bell DA; Yandell DW; Scully RE; Thor AD Am J Clin Pathol; 1994 Nov; 102(5):671-6. PubMed ID: 7942635 [TBL] [Abstract][Full Text] [Related]
18. Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor. Manegold E; Tietze L; Günther K; Fleischer A; Amo-Takyi BK; Schröder W; Handt S Hum Pathol; 2001 May; 32(5):559-62. PubMed ID: 11381376 [TBL] [Abstract][Full Text] [Related]
19. Centromere spreading and centromeric aberrations in ovarian tumors. Zhu D; Ma MS; Zhao RZ; Li MY Cancer Genet Cytogenet; 1995 Mar; 80(1):63-5. PubMed ID: 7697635 [TBL] [Abstract][Full Text] [Related]
20. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms. Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]